Title: Two long-acting hormonal contraceptive options.

POPLINE Document Number: 120762

Author(s):

Kaunitz AM
Jordan CW

Source citation:

CONTEMPORARY OB / GYN, 1997 Feb;42(2):27-8, 31, 35-6 passim.

Abstract:

Careful acceptor selection and individual counseling can maximize efficacy and patient satisfaction with the long-acting progestin contraceptives Norplant and Depo-Provera. Both methods should be administered within 5-7 days of the onset of menstruation to ensure the patient is not pregnant. Method initiation also can occur immediately after induced abortion or childbirth, with no adverse effect on lactation. Pregnancy rates average 0.8/100 woman-years during 5 years of use for implant users and 0.3/100 woman-years for Depo-Provera. Menstrual changes are the most significant side effect of long-acting progestins. These methods may be especially suited for adolescents who have problems complying with a daily pill regimen and women in whom estrogen use is contraindicated; those with psychiatric problems or mental retardation may also benefit from their convenience. The 14 brief case studies accompanying this review cover concerns such as reduced libido, thromboembolism history, weight gain, anticonvulsant drug use, and uterine fibroids.

Keywords:

Literature Review
Case Studies
Contraceptive Implants
Levonorgestrel
Depo-Provera
Counseling
Studies
Research Methodology
Contraceptive Methods
Contraception
Family Planning
Contraceptive Agents, Progestin
Contraceptive Agents, Female
Contraceptive Agents
Medroxyprogesterone Acetate
Clinic Activities
Program Activities
Programs
Organization and Administration